Early Neurodegeneration in the Brain of a Child Without Functional PKR-like Endoplasmic Reticulum Kinase

Journal of Neuropathology and Experimental Neurology

Volumn 74, Issue 8, 2015, Pages 850-857

  Bruch, Julius ^a,b   Kurz, Carolin ^a,b   Vasiljevic, Alexandre ^e   Nicolino, Marc ^f   Arzberger, Thomas ^c,d   Höglinger, Günter U ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e Groupement Hospitalier Est   (France)

^f HOSPICES CIVILS DE LYON   (France)

Author keywords

Alzheimer disease; Autophagy; FUS; p62; Parkinson disease; PERK; Tau; Wolcott Rallison syndrome

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; PHOSPHOTRANSFERASE; PROTEIN KINASE R LIKE ENDOPLASMIC RETICULUM KINASE; UNCLASSIFIED DRUG; EIF2AK3 PROTEIN, HUMAN; PROTEIN KINASE R;

ARTICLE; AUTOPSY; BONE DYSPLASIA; BONE RADIOGRAPHY; BRAIN; CASE REPORT; CHILD; CONTROLLED STUDY; EIF2AK3 GENE; ENZYME DEFICIENCY; GENE; GENE SEQUENCE; GENETIC SCREENING; GENOTYPING TECHNIQUE; HEART VENTRICLE ARRHYTHMIA; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; HYPOTENSION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MALE; NERVE DEGENERATION; PRESCHOOL CHILD; PRIORITY JOURNAL; WOLCOTT RALLISON SYNDROME; CHONDRODYSPLASIA; CONGENITAL MALFORMATION; DEFICIENCY; EPIPHYSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; PATHOLOGY;

BRAIN; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EIF-2 KINASE; EPIPHYSES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE DEGENERATION; OSTEOCHONDRODYSPLASIAS;

EID: 84938517319     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000224     Document Type: Article

References (29)

1. Wolcott CD, Rallison ML. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972;80:292-97
2. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis 2010;5:29
3. Castelnau P, Le Merrer M, Diatloff-Zito C, Marquis E, Tête MJ, Robert JJ. Wolcott-Rallison syndrome: A case with endocrine and exocrine pancreatic deficiency and pancreatic hypotrophy. Eur J Pediatr 2000;159:631-33
4. Iyer S, Korada M, Rainbow L, et al. Wolcott-Rallison syndrome: A clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 2004;93:1195-201
5. j/j mice reveals a role for translational control in secretory cell survival. Mol Cell 2001;7:1153-63
6. Trinh MA, Kaphzan H, Wek RC, Pierre P, Cavener DR, Klann E. Brain-specific disruption of the eIF2alpha kinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep 2012;1:676-88
7. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000;25:406-9
8. Abdel-Salam GM, Schaffer AE, Zaki MS, et al. A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS). Am J Med Genet A 2012;158A:2788-96
9. Cullinan SB, Zhang D, Hannink M, Arvisais E, Kaufman RJ, Diehl JA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol 2003;23:7198-209
10. Matsumoto H, Miyazaki S, Matsuyama S, et al. Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open 2013;2:1084-90
11. B'Chir W, Maurin AC, Carraro V, et al. The eIF2alpha/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res 2013;41:7683-99
12. Bouman L, Schlierf A, Lutz AK, et al. Parkin is transcriptionally regulated by ATF4: Evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 2011;18:769-82
13. Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol 2013;1:45-49
14. Cornejo VH, Hetz C. The unfolded protein response in Alzheimer's disease. Semin Immunopathol 2013;35:277-92
15. Hetz C, Chevet E, Harding HP. Targeting the unfolded protein response in disease. Nat Rev Drug Discov 2013;12:703-19
16. Hetz C, Mollereau B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat Rev Neurosci 2014;15:233-49
17. Hoozemans JJ, van Haastert ES, Nijholt DA, Rozemuller AJ, Eikelenboom P, Scheper W. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am J Pathol 2009;174:1241-51
18. Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W. Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 2007;354:707-11
19. Nijholt DA, van Haastert ES, Rozemuller AJ, Scheper W, Hoozemans JJ. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J Pathol 2012;226:693-702
20. Hoglinger GU, Melhem NM, Dickson DW, et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 2011;43:699-705
21. Avivar-Valderas A, Salas E, Bobrovnikova-Marjon E, et al. PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment. Mol Cell Biol 2011;31:3616-29
22. Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med 2013;19:983-97
23. Jiang TF, Zhang YJ, Zhou HY, et al. Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 2013;8:356-69
24. Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M. Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 2012;135:2169-77
25. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010;13:805-11
26. Collardeau-Frachon S, Vasiljevic A, Jouvet A, Bouvier R, Senée V, Nicolino M. Microscopic and ultrastructural features in Wolcott-Rallison syndrome, a permanent neonatal diabetes mellitus: About two autopsy cases. Pediatr Diabetes 2014. doi: 10.1111/pedi.12201 [Epub ahead of print]
27. Spehar Uroić A, Mulliqi Kotori V, Rojnić Putarek N, Kušec V, Dumić M. Primary hypothyroidism and nipple hypoplasia in a girl with Wolcott-Rallison syndrome. Eur J Pediatr 2014;173:529-31
28. Snowden JS, Hu Q, Rollinson S, et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol 2011;122:99-110
29. Goedert M, Jakes R, Vanmechelen E. Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-69